Strategies to optimize your intake The take-home message is quality, dose and delivery form, and duration matter, and they matter a lot
You can learn more about how our ingredients work by visiting our ingredients page
Skye started a Phase 2 clinical trial for its peripheral CB1 inhibitor, nimacimab, in August 2024 and expects to report topline data based on full enrollment in late Q3 or early Q4 2025
Fewer side effects, smoother adaptation period
Glutathione Peroxidase 2 (GPx-2) antibody Glutathione peroxidase 2, GPx-2, GSHPx-2 Gastrointestinal glutathione peroxidase Glutathione peroxidase-gastrointestinal, GPx-GI, GSHPx-GI Glutathione peroxidase-related protein 2, GPRP-2 Gene name : GPX2 Gastrointestinal glutathione peroxidase Glutathione peroxidase-gastrointestinal, GPx-GI, GSHPx-GI Glutathione peroxidase-related protein 2, GPRP-2 Gene name : GPX2 As low as $323.40 In stock Ref 00012995 Belongs to the glutathione peroxidase family